在患有炎症性肠道疾病的患者中同时出现慢性病,系统性审查和元分析
Xiaoping Han1,2, Zifeng Xu1,2, Yu Chang1,2
1Department of Gastroenterology, The First Hospital of Jilin University, Changchun, China.
Frontiers in medicine
|October 18, 2024
概括
这项元分析发现,慢性病 (CKD) 在炎症性肠病 (IBD) 患者中的患病率为5%,CKD的风险明显更高. 建议对IBD患者进行定期的CKD监测.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 胃肠病学 胃肠病学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 炎症性肠病 (IBD) 是一种多器官自身免疫性疾病,影响胃肠道和潜在的其他器官.
- 脏参与IBD,包括慢性脏病 (CKD) 和末期脏病 (ESRD),不太了解,以前的关联产生不一致的结果.
研究的目的:
- 分析诊断为IBD的患者同时患有CKD和ESRD的患病率.
- 确定IBD患者中CKD和ESRD的风险.
主要方法:
- 在PubMed,Cochrane,Web of Science和Embase进行了系统的文献搜索,搜索到2023年10月之前发表的研究.
- 包括的研究集中在IBD患者同时患有CKD或ESRD,分析发病率和几率比率 (OR).
- 使用纽卡斯尔-太华尺度评估研究质量,并进行敏感性和出版偏差分析.
主要成果:
- 包括9项研究. 在239,042名IBD患者中,CKD的综合流行率为5% (95%CI:1-9%).
- 在40341名IBD患者中,ESRD的综合患病率为0.2% (95% CI: -0.08-0.12%).
- 六项病例控制研究表明,IBD患者的CKD风险显著增加 (OR1.36,95% CI:1.08-1.70,p=0.008).
结论:
- 虽然研究表明IBD中CKD风险增加,但最终结论受到研究数量和异质性的限制.
- 建议对患有炎性肠病的患者进行定期的CKD监测.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
189
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
189
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
322
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
322
Chronic Bowel Disorders: Introduction
394
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
394
Inflammatory Bowel Disease I: Ulcerative Colitis
146
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
146
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...


